Literature DB >> 22773448

Role of heparan sulfate in sexually transmitted infections.

Vaibhav Tiwari1, Erika Maus, Ira M Sigar, Kyle H Ramsey, Deepak Shukla.   

Abstract

Cell surface heparan sulfate (HS), a polysaccharide composed of alternating uronic acid and glucosamine residues, represents a common link that many sexually transmitted infections (STIs) require for infection. Variable modifications within the monomeric units of HS chains together with their unique structural conformations generate heterogeneity, which expands the ability of HS to bind a diverse array of host and microbial proteins. Recent advances made in the field of glycobiology have critically enhanced our understanding of HS and its interactions with microbes and their significance in important human diseases. The role of HS has been elaborated for several STIs to include those caused by herpes simplex virus, human immunodeficiency virus, human papillomavirus, and Chlamydia. In addition, gonorrhea, syphilis, and yeast infections are also dependent on the presence of HS on human target cells. Critical steps such as pathogen adhesion or binding to host cells followed by internalization to enhance intracellular survival and possible spread to other cells are mediated by HS. In addition, HS guided cell signaling plays a role in the development of angiogenesis and inflammation associated with many STIs. Past and ongoing investigations are providing new push for the development of HS-mimetics and analogs as novel prevention strategies against many different STIs. This review article summarizes the significance of HS in STIs and describes how emerging new products that target HS can be used to control the spread of STIs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22773448      PMCID: PMC3481906          DOI: 10.1093/glycob/cws106

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  125 in total

1.  Further evidence that papillomavirus capsids exist in two distinct conformations.

Authors:  Hans-Christoph Selinka; Tzenan Giroglou; Thorsten Nowak; Neil D Christensen; Martin Sapp
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

2.  Chlamydia trachomatis glycosaminoglycan-dependent and independent attachment to eukaryotic cells.

Authors:  J C Chen; R S Stephens
Journal:  Microb Pathog       Date:  1997-01       Impact factor: 3.738

3.  Serum lipoprotein binding by Treponema pallidum: possible role for proteoglycans.

Authors:  J F Alderete; J B Baseman
Journal:  Genitourin Med       Date:  1989-06

4.  Herpes simplex virus types 1 and 2 differ in their interaction with heparan sulfate.

Authors:  E Trybala; J A Liljeqvist; B Svennerholm; T Bergström
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

5.  Receptor-binding properties of a soluble form of human cytomegalovirus glycoprotein B.

Authors:  K A Boyle; T Compton
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

6.  A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry.

Authors:  D Shukla; J Liu; P Blaiklock; N W Shworak; X Bai; J D Esko; G H Cohen; R J Eisenberg; R D Rosenberg; P G Spear
Journal:  Cell       Date:  1999-10-01       Impact factor: 41.582

7.  Specificity and affinity of binding of herpes simplex virus type 2 glycoprotein B to glycosaminoglycans.

Authors:  R K Williams; S E Straus
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

8.  Expression of heparan sulfate D-glucosaminyl 3-O-sulfotransferase isoforms reveals novel substrate specificities.

Authors:  J Liu; N W Shworak; P Sinaÿ; J J Schwartz; L Zhang; L M Fritze; R D Rosenberg
Journal:  J Biol Chem       Date:  1999-02-19       Impact factor: 5.157

Review 9.  Polysulfated/sulfonated compounds for the development of drugs at the crossroad of viral infection and oncogenesis.

Authors:  Marco Rusnati; Chiara Urbinati
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

10.  Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans.

Authors:  Andreas Schulze; Philippe Gripon; Stephan Urban
Journal:  Hepatology       Date:  2007-12       Impact factor: 17.425

View more
  28 in total

1.  Genome-Wide Screening Uncovers the Significance of N-Sulfation of Heparan Sulfate as a Host Cell Factor for Chikungunya Virus Infection.

Authors:  Atsushi Tanaka; Uranan Tumkosit; Shota Nakamura; Daisuke Motooka; Natsuko Kishishita; Thongkoon Priengprom; Areerat Sa-Ngasang; Taroh Kinoshita; Naokazu Takeda; Yusuke Maeda
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

2.  Heparan Sulfate Modulates Neutrophil and Endothelial Function in Antibacterial Innate Immunity.

Authors:  Ding Xu; Joshua Olson; Jason N Cole; Xander M van Wijk; Volker Brinkmann; Arturo Zychlinsky; Victor Nizet; Jeffrey D Esko; Yung-Chi Chang
Journal:  Infect Immun       Date:  2015-07-06       Impact factor: 3.441

Review 3.  The sweet spot: defining virus-sialic acid interactions.

Authors:  Jennifer E Stencel-Baerenwald; Kerstin Reiss; Dirk M Reiter; Thilo Stehle; Terence S Dermody
Journal:  Nat Rev Microbiol       Date:  2014-09-29       Impact factor: 60.633

4.  Viral Activation of Heparanase Drives Pathogenesis of Herpes Simplex Virus-1.

Authors:  Alex M Agelidis; Satvik R Hadigal; Dinesh Jaishankar; Deepak Shukla
Journal:  Cell Rep       Date:  2017-07-11       Impact factor: 9.423

Review 5.  Role of heparan sulfate in ocular diseases.

Authors:  Paul J Park; Deepak Shukla
Journal:  Exp Eye Res       Date:  2013-02-11       Impact factor: 3.467

6.  Comprehensive analysis of herpes simplex virus 1 (HSV-1) entry mediated by zebrafish 3-O-Sulfotransferase isoforms: implications for the development of a zebrafish model of HSV-1 infection.

Authors:  Abraam M Yakoub; Nistha Rawal; Erika Maus; John Baldwin; Deepak Shukla; Vaibhav Tiwari
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

7.  Zebrafish encoded 3-O-sulfotransferase-2 generated heparan sulfate serves as a receptor during HSV-1 entry and spread.

Authors:  John Baldwin; Thessicar E Antoine; Deepak Shukla; Vaibhav Tiwari
Journal:  Biochem Biophys Res Commun       Date:  2013-02-15       Impact factor: 3.575

8.  Agmatine-containing poly(amidoamine)s as a novel class of antiviral macromolecules: structural properties and in vitro evaluation of infectivity inhibition.

Authors:  Manuela Donalisio; Elisabetta Ranucci; Valeria Cagno; Andrea Civra; Amedea Manfredi; Roberta Cavalli; Paolo Ferruti; David Lembo
Journal:  Antimicrob Agents Chemother       Date:  2014-08-04       Impact factor: 5.191

9.  Endosulfatases SULF1 and SULF2 limit Chlamydia muridarum infection.

Authors:  J H Kim; C Chan; C Elwell; M S Singer; T Dierks; H Lemjabbar-Alaoui; S D Rosen; J N Engel
Journal:  Cell Microbiol       Date:  2013-04-09       Impact factor: 3.715

Review 10.  Mechanistic and therapeutic overview of glycosaminoglycans: the unsung heroes of biomolecular signaling.

Authors:  Khushboo Gulati; Krishna Mohan Poluri
Journal:  Glycoconj J       Date:  2015-12-03       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.